Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedFooter revision label updated from v3.6.3 to v3.6.4, indicating a small platform update to the history page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page history shows Revision: v3.6.3 replacing Revision: v3.6.2, indicating a minor site version update rather than changes to trial information.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page’s revision label updates from Revision: v3.6.0 to Revision: v3.6.2, signaling a newer site release without changing the study history content.SummaryDifference0.0%

- Check45 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating no active enrollment. The version history shows a new Revision: v3.6.0, replacing the prior Revision: v3.5.5.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page footer was updated to Revision: v3.5.5, replacing the previous Revision: v3.5.4. This update reflects a new build/version of the page in the study history viewer.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor site version update.SummaryDifference0.0%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.